A study to evaluate the effect of Krishna Tila Churna with Navneet in Raktja Arsha (Haemorrhoids).

A single arm clinical study to evaluate the efficacy of Krishna tila churna with navneet in Raktaja arsha.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/11/038138

Enrollment

Registered

2021-11-18

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed as Raktja Arsha. 2) 1st and 2nd degree haemorrhoids. 3) Patients of age group between 18 upto 60 years irrespective of gender will be included.

Exclusion criteria

Exclusion criteria: 1) Patients not willing for trial 2) Pregnant women 3) Patients that need surgical intervention 4) Diseases like Ulcerative colitis, Crohns disease, TB of colon or rectum, Rectal prolapse, CA of rectum or an malignancy

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Krishna Tila Churna with Navneet in management of Rakatja Arsha.Timepoint: The drug will be given twice a day for 7 days. Follow-ups will be on 3rd and 7th day. Total duration of the study will be 7 days.	—

Secondary

Measure	Time frame
1) To observe the adverse effects of the drug.Timepoint: The drug will be given twice a day for 7 days. Follow-ups will be on 3rd and 7th day. Total duration of study will be 7 days.	—

Countries

India

Contacts

Public ContactDR ATUL VITTHAL PATIL

DR D Y PATIL COLLEGE OF AYURVED AND RESEARCH CENTRE PIMPRI PUNE 18

dratulpatil85@gmail.com9405659585

Outcome results